Anticoagulant

Rivaroxaban (XARELTO) Tablet

$102.00

XARELTO Tablet offers a convenient and effective option for anticoagulation therapy, catering to the diverse needs of patients requiring thromboprophylaxis and treatment of thromboembolic disorders.

Strength	Choose an option2.5mg10mg15mg20mg
	Clear

Quantity

Rivaroxaban (XARELTO) Tablet quantity

Add to cart

Sku:

N/A

Tag:

Rivaroxaban

Description

XARELTO Tablet, containing Rivaroxaban in strengths of 2.5mg, 10mg, 15mg, and 20mg, is a medication primarily prescribed for anticoagulation therapy. It is used to prevent blood clots in patients with various conditions, such as atrial fibrillation, deep vein thrombosis, pulmonary embolism, and after certain surgical procedures.

Key Features:

• Anticoagulant Therapy: XARELTO Tablet contains Rivaroxaban, an oral anticoagulant that inhibits clot formation by directly targeting factor Xa, an essential component of the coagulation cascade.
• Dose Variability: Available in multiple strengths (2.5mg, 10mg, 15mg, and 20mg), allowing for individualized dosing based on the patient’s specific medical condition, risk factors, and response to treatment.
• Versatile Indications: XARELTO is indicated for various clinical scenarios, including stroke prevention in atrial fibrillation, treatment and prevention of deep vein thrombosis and pulmonary embolism, and prophylaxis of thromboembolism after hip or knee replacement surgery.
• Once-Daily Dosage: Typically administered once daily, XARELTO offers convenient dosing, enhancing patient adherence to therapy.
• Rapid Onset and Offset of Action: Rivaroxaban exhibits rapid onset of action, providing prompt anticoagulant effects, and has a relatively short half-life, allowing for quick reversal if necessary.
• Reduced Monitoring Requirements: Unlike traditional anticoagulants such as warfarin, Rivaroxaban does not require routine monitoring of blood levels or frequent dosage adjustments, simplifying management.
• Potential Adverse Effects: While generally well-tolerated, XARELTO may increase the risk of bleeding, particularly in patients with certain risk factors such as renal impairment or concomitant use of other anticoagulants or antiplatelet agents.
• Individualized Therapy: The selection of the appropriate XARELTO dosage should be based on factors such as renal function, concomitant medications, and the specific indication for anticoagulation.

Additional information